SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2237980, encodeId=c1a1223e98000, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：消化道肿瘤 经验分享：7月份投稿，9月份大修，一拒一修，编辑给大修，10月份修回被拒，拒稿的审稿人强烈建议进行前瞻性实验，AE也建议前瞻，但是这项研究前瞻性过不了伦理。大家觉得argue有用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Wed Nov 20 14:01:14 CST 2024, time=2024-11-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215509, encodeId=e336221550931, content=偏重的研究方向：内镜 经验分享：with editor两个月，催稿后直接拒了，编辑那超级慢，不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25bf5324886, createdName=JOY@111, createdTime=Wed Jul 17 22:15:10 CST 2024, time=2024-07-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2161031, encodeId=c9032161031d1, content=偏重的研究方向：手术;胃癌 经验分享：各位前辈，为何投稿后5天还是new submission? 需要所有作者通过邮件确认作者后编辑才会处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 05 12:04:24 CST 2023, time=2023-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=925418, encodeId=6e519254188a, content=投稿20多天就小修，修回后十几天就接收，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Fri Feb 19 10:39:47 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153424, encodeId=d3652153424cb, content=偏重的研究方向：肝胆胰脾的微创治疗;endoscopy;内镜 经验分享：8.2开始editor assigned半个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Fri Aug 18 16:56:10 CST 2023, time=2023-08-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2176172, encodeId=d63c21e617292, content=请问大修，一个审稿人全是评论，另外一位审稿人给了修改意见，大修通过率大概是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a08760050, createdName=ms6000000523905696, createdTime=Wed Dec 20 19:34:44 CST 2023, time=2023-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178961, encodeId=66e421e8961f1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科;胃癌 经验分享：腹腔镜手术术式投稿。投稿2月给出大修意见，修改提交后10余天接收。想问一下，接收后大约多久会收到缴费的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Wed Jan 03 10:01:09 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195169, encodeId=c7bb2195169fe, content=我想咨询一下各位老师，接受后多久收到OA或者非OA通知，以及Proof，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e435309968, createdName=14885ad9m72(暂无昵称), createdTime=Mon Mar 25 10:57:03 CST 2024, time=2024-03-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2181044, encodeId=89a621810446c, content=偏重的研究方向：外科;胃癌 经验分享：请问下，接收后多久会发来proof？接收了20天还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Fri Jan 12 19:56:56 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1192317, encodeId=0a27119231eec, content=有人弄过这个杂志的visual abstract嘛。编辑要求添加这个，但是我没在官网上找到示例。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Fri Feb 11 13:40:44 CST 2022, time=2022-02-11, status=1, ipAttribution=)]

2024-11-20 ms6000000691767799 来自福建省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：消化道肿瘤
经验分享：7月份投稿，9月份大修，一拒一修，编辑给大修，10月份修回被拒，拒稿的审稿人强烈建议进行前瞻性实验，AE也建议前瞻，但是这项研究前瞻性过不了伦理。大家觉得argue有用吗？

23 0

[GetPortalCommentsPageByObjectIdResponse(id=2237980, encodeId=c1a1223e98000, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：消化道肿瘤 经验分享：7月份投稿，9月份大修，一拒一修，编辑给大修，10月份修回被拒，拒稿的审稿人强烈建议进行前瞻性实验，AE也建议前瞻，但是这项研究前瞻性过不了伦理。大家觉得argue有用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Wed Nov 20 14:01:14 CST 2024, time=2024-11-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215509, encodeId=e336221550931, content=偏重的研究方向：内镜 经验分享：with editor两个月，催稿后直接拒了，编辑那超级慢，不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25bf5324886, createdName=JOY@111, createdTime=Wed Jul 17 22:15:10 CST 2024, time=2024-07-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2161031, encodeId=c9032161031d1, content=偏重的研究方向：手术;胃癌 经验分享：各位前辈，为何投稿后5天还是new submission? 需要所有作者通过邮件确认作者后编辑才会处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 05 12:04:24 CST 2023, time=2023-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=925418, encodeId=6e519254188a, content=投稿20多天就小修，修回后十几天就接收，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Fri Feb 19 10:39:47 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153424, encodeId=d3652153424cb, content=偏重的研究方向：肝胆胰脾的微创治疗;endoscopy;内镜 经验分享：8.2开始editor assigned半个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Fri Aug 18 16:56:10 CST 2023, time=2023-08-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2176172, encodeId=d63c21e617292, content=请问大修，一个审稿人全是评论，另外一位审稿人给了修改意见，大修通过率大概是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a08760050, createdName=ms6000000523905696, createdTime=Wed Dec 20 19:34:44 CST 2023, time=2023-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178961, encodeId=66e421e8961f1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科;胃癌 经验分享：腹腔镜手术术式投稿。投稿2月给出大修意见，修改提交后10余天接收。想问一下，接收后大约多久会收到缴费的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Wed Jan 03 10:01:09 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195169, encodeId=c7bb2195169fe, content=我想咨询一下各位老师，接受后多久收到OA或者非OA通知，以及Proof，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e435309968, createdName=14885ad9m72(暂无昵称), createdTime=Mon Mar 25 10:57:03 CST 2024, time=2024-03-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2181044, encodeId=89a621810446c, content=偏重的研究方向：外科;胃癌 经验分享：请问下，接收后多久会发来proof？接收了20天还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Fri Jan 12 19:56:56 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1192317, encodeId=0a27119231eec, content=有人弄过这个杂志的visual abstract嘛。编辑要求添加这个，但是我没在官网上找到示例。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Fri Feb 11 13:40:44 CST 2022, time=2022-02-11, status=1, ipAttribution=)]

2024-07-17 JOY@111 来自江西省

偏重的研究方向：内镜
经验分享：with editor两个月，催稿后直接拒了，编辑那超级慢，不会再投

64 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237980, encodeId=c1a1223e98000, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：消化道肿瘤 经验分享：7月份投稿，9月份大修，一拒一修，编辑给大修，10月份修回被拒，拒稿的审稿人强烈建议进行前瞻性实验，AE也建议前瞻，但是这项研究前瞻性过不了伦理。大家觉得argue有用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Wed Nov 20 14:01:14 CST 2024, time=2024-11-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215509, encodeId=e336221550931, content=偏重的研究方向：内镜 经验分享：with editor两个月，催稿后直接拒了，编辑那超级慢，不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25bf5324886, createdName=JOY@111, createdTime=Wed Jul 17 22:15:10 CST 2024, time=2024-07-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2161031, encodeId=c9032161031d1, content=偏重的研究方向：手术;胃癌 经验分享：各位前辈，为何投稿后5天还是new submission? 需要所有作者通过邮件确认作者后编辑才会处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 05 12:04:24 CST 2023, time=2023-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=925418, encodeId=6e519254188a, content=投稿20多天就小修，修回后十几天就接收，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Fri Feb 19 10:39:47 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153424, encodeId=d3652153424cb, content=偏重的研究方向：肝胆胰脾的微创治疗;endoscopy;内镜 经验分享：8.2开始editor assigned半个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Fri Aug 18 16:56:10 CST 2023, time=2023-08-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2176172, encodeId=d63c21e617292, content=请问大修，一个审稿人全是评论，另外一位审稿人给了修改意见，大修通过率大概是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a08760050, createdName=ms6000000523905696, createdTime=Wed Dec 20 19:34:44 CST 2023, time=2023-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178961, encodeId=66e421e8961f1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科;胃癌 经验分享：腹腔镜手术术式投稿。投稿2月给出大修意见，修改提交后10余天接收。想问一下，接收后大约多久会收到缴费的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Wed Jan 03 10:01:09 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195169, encodeId=c7bb2195169fe, content=我想咨询一下各位老师，接受后多久收到OA或者非OA通知，以及Proof，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e435309968, createdName=14885ad9m72(暂无昵称), createdTime=Mon Mar 25 10:57:03 CST 2024, time=2024-03-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2181044, encodeId=89a621810446c, content=偏重的研究方向：外科;胃癌 经验分享：请问下，接收后多久会发来proof？接收了20天还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Fri Jan 12 19:56:56 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1192317, encodeId=0a27119231eec, content=有人弄过这个杂志的visual abstract嘛。编辑要求添加这个，但是我没在官网上找到示例。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Fri Feb 11 13:40:44 CST 2022, time=2022-02-11, status=1, ipAttribution=)]

2023-10-05 ms9000001935138113 来自辽宁省

偏重的研究方向：手术;胃癌
经验分享：各位前辈，为何投稿后5天还是new submission? 需要所有作者通过邮件确认作者后编辑才会处理吗？

121 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237980, encodeId=c1a1223e98000, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：消化道肿瘤 经验分享：7月份投稿，9月份大修，一拒一修，编辑给大修，10月份修回被拒，拒稿的审稿人强烈建议进行前瞻性实验，AE也建议前瞻，但是这项研究前瞻性过不了伦理。大家觉得argue有用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Wed Nov 20 14:01:14 CST 2024, time=2024-11-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215509, encodeId=e336221550931, content=偏重的研究方向：内镜 经验分享：with editor两个月，催稿后直接拒了，编辑那超级慢，不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25bf5324886, createdName=JOY@111, createdTime=Wed Jul 17 22:15:10 CST 2024, time=2024-07-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2161031, encodeId=c9032161031d1, content=偏重的研究方向：手术;胃癌 经验分享：各位前辈，为何投稿后5天还是new submission? 需要所有作者通过邮件确认作者后编辑才会处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 05 12:04:24 CST 2023, time=2023-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=925418, encodeId=6e519254188a, content=投稿20多天就小修，修回后十几天就接收，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Fri Feb 19 10:39:47 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153424, encodeId=d3652153424cb, content=偏重的研究方向：肝胆胰脾的微创治疗;endoscopy;内镜 经验分享：8.2开始editor assigned半个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Fri Aug 18 16:56:10 CST 2023, time=2023-08-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2176172, encodeId=d63c21e617292, content=请问大修，一个审稿人全是评论，另外一位审稿人给了修改意见，大修通过率大概是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a08760050, createdName=ms6000000523905696, createdTime=Wed Dec 20 19:34:44 CST 2023, time=2023-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178961, encodeId=66e421e8961f1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科;胃癌 经验分享：腹腔镜手术术式投稿。投稿2月给出大修意见，修改提交后10余天接收。想问一下，接收后大约多久会收到缴费的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Wed Jan 03 10:01:09 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195169, encodeId=c7bb2195169fe, content=我想咨询一下各位老师，接受后多久收到OA或者非OA通知，以及Proof，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e435309968, createdName=14885ad9m72(暂无昵称), createdTime=Mon Mar 25 10:57:03 CST 2024, time=2024-03-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2181044, encodeId=89a621810446c, content=偏重的研究方向：外科;胃癌 经验分享：请问下，接收后多久会发来proof？接收了20天还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Fri Jan 12 19:56:56 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1192317, encodeId=0a27119231eec, content=有人弄过这个杂志的visual abstract嘛。编辑要求添加这个，但是我没在官网上找到示例。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Fri Feb 11 13:40:44 CST 2022, time=2022-02-11, status=1, ipAttribution=)]

2021-02-19 147a5940m05暂无昵称

投稿20多天就小修，修回后十几天就接收，很快

184 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237980, encodeId=c1a1223e98000, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：消化道肿瘤 经验分享：7月份投稿，9月份大修，一拒一修，编辑给大修，10月份修回被拒，拒稿的审稿人强烈建议进行前瞻性实验，AE也建议前瞻，但是这项研究前瞻性过不了伦理。大家觉得argue有用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Wed Nov 20 14:01:14 CST 2024, time=2024-11-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215509, encodeId=e336221550931, content=偏重的研究方向：内镜 经验分享：with editor两个月，催稿后直接拒了，编辑那超级慢，不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25bf5324886, createdName=JOY@111, createdTime=Wed Jul 17 22:15:10 CST 2024, time=2024-07-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2161031, encodeId=c9032161031d1, content=偏重的研究方向：手术;胃癌 经验分享：各位前辈，为何投稿后5天还是new submission? 需要所有作者通过邮件确认作者后编辑才会处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 05 12:04:24 CST 2023, time=2023-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=925418, encodeId=6e519254188a, content=投稿20多天就小修，修回后十几天就接收，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Fri Feb 19 10:39:47 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153424, encodeId=d3652153424cb, content=偏重的研究方向：肝胆胰脾的微创治疗;endoscopy;内镜 经验分享：8.2开始editor assigned半个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Fri Aug 18 16:56:10 CST 2023, time=2023-08-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2176172, encodeId=d63c21e617292, content=请问大修，一个审稿人全是评论，另外一位审稿人给了修改意见，大修通过率大概是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a08760050, createdName=ms6000000523905696, createdTime=Wed Dec 20 19:34:44 CST 2023, time=2023-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178961, encodeId=66e421e8961f1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科;胃癌 经验分享：腹腔镜手术术式投稿。投稿2月给出大修意见，修改提交后10余天接收。想问一下，接收后大约多久会收到缴费的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Wed Jan 03 10:01:09 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195169, encodeId=c7bb2195169fe, content=我想咨询一下各位老师，接受后多久收到OA或者非OA通知，以及Proof，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e435309968, createdName=14885ad9m72(暂无昵称), createdTime=Mon Mar 25 10:57:03 CST 2024, time=2024-03-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2181044, encodeId=89a621810446c, content=偏重的研究方向：外科;胃癌 经验分享：请问下，接收后多久会发来proof？接收了20天还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Fri Jan 12 19:56:56 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1192317, encodeId=0a27119231eec, content=有人弄过这个杂志的visual abstract嘛。编辑要求添加这个，但是我没在官网上找到示例。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Fri Feb 11 13:40:44 CST 2022, time=2022-02-11, status=1, ipAttribution=)]

2023-08-18 ms3000001727854429 来自四川省

偏重的研究方向：肝胆胰脾的微创治疗;endoscopy;内镜
经验分享：8.2开始editor assigned半个多月了

124 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237980, encodeId=c1a1223e98000, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：消化道肿瘤 经验分享：7月份投稿，9月份大修，一拒一修，编辑给大修，10月份修回被拒，拒稿的审稿人强烈建议进行前瞻性实验，AE也建议前瞻，但是这项研究前瞻性过不了伦理。大家觉得argue有用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Wed Nov 20 14:01:14 CST 2024, time=2024-11-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215509, encodeId=e336221550931, content=偏重的研究方向：内镜 经验分享：with editor两个月，催稿后直接拒了，编辑那超级慢，不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25bf5324886, createdName=JOY@111, createdTime=Wed Jul 17 22:15:10 CST 2024, time=2024-07-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2161031, encodeId=c9032161031d1, content=偏重的研究方向：手术;胃癌 经验分享：各位前辈，为何投稿后5天还是new submission? 需要所有作者通过邮件确认作者后编辑才会处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 05 12:04:24 CST 2023, time=2023-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=925418, encodeId=6e519254188a, content=投稿20多天就小修，修回后十几天就接收，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Fri Feb 19 10:39:47 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153424, encodeId=d3652153424cb, content=偏重的研究方向：肝胆胰脾的微创治疗;endoscopy;内镜 经验分享：8.2开始editor assigned半个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Fri Aug 18 16:56:10 CST 2023, time=2023-08-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2176172, encodeId=d63c21e617292, content=请问大修，一个审稿人全是评论，另外一位审稿人给了修改意见，大修通过率大概是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a08760050, createdName=ms6000000523905696, createdTime=Wed Dec 20 19:34:44 CST 2023, time=2023-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178961, encodeId=66e421e8961f1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科;胃癌 经验分享：腹腔镜手术术式投稿。投稿2月给出大修意见，修改提交后10余天接收。想问一下，接收后大约多久会收到缴费的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Wed Jan 03 10:01:09 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195169, encodeId=c7bb2195169fe, content=我想咨询一下各位老师，接受后多久收到OA或者非OA通知，以及Proof，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e435309968, createdName=14885ad9m72(暂无昵称), createdTime=Mon Mar 25 10:57:03 CST 2024, time=2024-03-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2181044, encodeId=89a621810446c, content=偏重的研究方向：外科;胃癌 经验分享：请问下，接收后多久会发来proof？接收了20天还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Fri Jan 12 19:56:56 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1192317, encodeId=0a27119231eec, content=有人弄过这个杂志的visual abstract嘛。编辑要求添加这个，但是我没在官网上找到示例。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Fri Feb 11 13:40:44 CST 2022, time=2022-02-11, status=1, ipAttribution=)]

2023-12-20 ms6000000523905696

请问大修，一个审稿人全是评论，另外一位审稿人给了修改意见，大修通过率大概是多少啊

127 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237980, encodeId=c1a1223e98000, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：消化道肿瘤 经验分享：7月份投稿，9月份大修，一拒一修，编辑给大修，10月份修回被拒，拒稿的审稿人强烈建议进行前瞻性实验，AE也建议前瞻，但是这项研究前瞻性过不了伦理。大家觉得argue有用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Wed Nov 20 14:01:14 CST 2024, time=2024-11-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215509, encodeId=e336221550931, content=偏重的研究方向：内镜 经验分享：with editor两个月，催稿后直接拒了，编辑那超级慢，不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25bf5324886, createdName=JOY@111, createdTime=Wed Jul 17 22:15:10 CST 2024, time=2024-07-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2161031, encodeId=c9032161031d1, content=偏重的研究方向：手术;胃癌 经验分享：各位前辈，为何投稿后5天还是new submission? 需要所有作者通过邮件确认作者后编辑才会处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 05 12:04:24 CST 2023, time=2023-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=925418, encodeId=6e519254188a, content=投稿20多天就小修，修回后十几天就接收，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Fri Feb 19 10:39:47 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153424, encodeId=d3652153424cb, content=偏重的研究方向：肝胆胰脾的微创治疗;endoscopy;内镜 经验分享：8.2开始editor assigned半个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Fri Aug 18 16:56:10 CST 2023, time=2023-08-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2176172, encodeId=d63c21e617292, content=请问大修，一个审稿人全是评论，另外一位审稿人给了修改意见，大修通过率大概是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a08760050, createdName=ms6000000523905696, createdTime=Wed Dec 20 19:34:44 CST 2023, time=2023-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178961, encodeId=66e421e8961f1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科;胃癌 经验分享：腹腔镜手术术式投稿。投稿2月给出大修意见，修改提交后10余天接收。想问一下，接收后大约多久会收到缴费的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Wed Jan 03 10:01:09 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195169, encodeId=c7bb2195169fe, content=我想咨询一下各位老师，接受后多久收到OA或者非OA通知，以及Proof，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e435309968, createdName=14885ad9m72(暂无昵称), createdTime=Mon Mar 25 10:57:03 CST 2024, time=2024-03-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2181044, encodeId=89a621810446c, content=偏重的研究方向：外科;胃癌 经验分享：请问下，接收后多久会发来proof？接收了20天还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Fri Jan 12 19:56:56 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1192317, encodeId=0a27119231eec, content=有人弄过这个杂志的visual abstract嘛。编辑要求添加这个，但是我没在官网上找到示例。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Fri Feb 11 13:40:44 CST 2022, time=2022-02-11, status=1, ipAttribution=)]

2024-01-03 ms9000001935138113 来自北京

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：外科;胃癌
经验分享：腹腔镜手术术式投稿。投稿2月给出大修意见，修改提交后10余天接收。想问一下，接收后大约多久会收到缴费的邮件？

101 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237980, encodeId=c1a1223e98000, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：消化道肿瘤 经验分享：7月份投稿，9月份大修，一拒一修，编辑给大修，10月份修回被拒，拒稿的审稿人强烈建议进行前瞻性实验，AE也建议前瞻，但是这项研究前瞻性过不了伦理。大家觉得argue有用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Wed Nov 20 14:01:14 CST 2024, time=2024-11-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215509, encodeId=e336221550931, content=偏重的研究方向：内镜 经验分享：with editor两个月，催稿后直接拒了，编辑那超级慢，不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25bf5324886, createdName=JOY@111, createdTime=Wed Jul 17 22:15:10 CST 2024, time=2024-07-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2161031, encodeId=c9032161031d1, content=偏重的研究方向：手术;胃癌 经验分享：各位前辈，为何投稿后5天还是new submission? 需要所有作者通过邮件确认作者后编辑才会处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 05 12:04:24 CST 2023, time=2023-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=925418, encodeId=6e519254188a, content=投稿20多天就小修，修回后十几天就接收，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Fri Feb 19 10:39:47 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153424, encodeId=d3652153424cb, content=偏重的研究方向：肝胆胰脾的微创治疗;endoscopy;内镜 经验分享：8.2开始editor assigned半个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Fri Aug 18 16:56:10 CST 2023, time=2023-08-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2176172, encodeId=d63c21e617292, content=请问大修，一个审稿人全是评论，另外一位审稿人给了修改意见，大修通过率大概是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a08760050, createdName=ms6000000523905696, createdTime=Wed Dec 20 19:34:44 CST 2023, time=2023-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178961, encodeId=66e421e8961f1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科;胃癌 经验分享：腹腔镜手术术式投稿。投稿2月给出大修意见，修改提交后10余天接收。想问一下，接收后大约多久会收到缴费的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Wed Jan 03 10:01:09 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195169, encodeId=c7bb2195169fe, content=我想咨询一下各位老师，接受后多久收到OA或者非OA通知，以及Proof，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e435309968, createdName=14885ad9m72(暂无昵称), createdTime=Mon Mar 25 10:57:03 CST 2024, time=2024-03-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2181044, encodeId=89a621810446c, content=偏重的研究方向：外科;胃癌 经验分享：请问下，接收后多久会发来proof？接收了20天还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Fri Jan 12 19:56:56 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1192317, encodeId=0a27119231eec, content=有人弄过这个杂志的visual abstract嘛。编辑要求添加这个，但是我没在官网上找到示例。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Fri Feb 11 13:40:44 CST 2022, time=2022-02-11, status=1, ipAttribution=)]

2024-03-25 14885ad9m72(暂无昵称) 来自江苏省

我想咨询一下各位老师，接受后多久收到OA或者非OA通知，以及Proof，感谢

100 0

[GetPortalCommentsPageByObjectIdResponse(id=2237980, encodeId=c1a1223e98000, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：消化道肿瘤 经验分享：7月份投稿，9月份大修，一拒一修，编辑给大修，10月份修回被拒，拒稿的审稿人强烈建议进行前瞻性实验，AE也建议前瞻，但是这项研究前瞻性过不了伦理。大家觉得argue有用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Wed Nov 20 14:01:14 CST 2024, time=2024-11-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215509, encodeId=e336221550931, content=偏重的研究方向：内镜 经验分享：with editor两个月，催稿后直接拒了，编辑那超级慢，不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25bf5324886, createdName=JOY@111, createdTime=Wed Jul 17 22:15:10 CST 2024, time=2024-07-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2161031, encodeId=c9032161031d1, content=偏重的研究方向：手术;胃癌 经验分享：各位前辈，为何投稿后5天还是new submission? 需要所有作者通过邮件确认作者后编辑才会处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 05 12:04:24 CST 2023, time=2023-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=925418, encodeId=6e519254188a, content=投稿20多天就小修，修回后十几天就接收，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Fri Feb 19 10:39:47 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153424, encodeId=d3652153424cb, content=偏重的研究方向：肝胆胰脾的微创治疗;endoscopy;内镜 经验分享：8.2开始editor assigned半个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Fri Aug 18 16:56:10 CST 2023, time=2023-08-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2176172, encodeId=d63c21e617292, content=请问大修，一个审稿人全是评论，另外一位审稿人给了修改意见，大修通过率大概是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a08760050, createdName=ms6000000523905696, createdTime=Wed Dec 20 19:34:44 CST 2023, time=2023-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178961, encodeId=66e421e8961f1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科;胃癌 经验分享：腹腔镜手术术式投稿。投稿2月给出大修意见，修改提交后10余天接收。想问一下，接收后大约多久会收到缴费的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Wed Jan 03 10:01:09 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195169, encodeId=c7bb2195169fe, content=我想咨询一下各位老师，接受后多久收到OA或者非OA通知，以及Proof，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e435309968, createdName=14885ad9m72(暂无昵称), createdTime=Mon Mar 25 10:57:03 CST 2024, time=2024-03-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2181044, encodeId=89a621810446c, content=偏重的研究方向：外科;胃癌 经验分享：请问下，接收后多久会发来proof？接收了20天还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Fri Jan 12 19:56:56 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1192317, encodeId=0a27119231eec, content=有人弄过这个杂志的visual abstract嘛。编辑要求添加这个，但是我没在官网上找到示例。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Fri Feb 11 13:40:44 CST 2022, time=2022-02-11, status=1, ipAttribution=)]

2024-01-12 ms9000001935138113 来自北京

偏重的研究方向：外科;胃癌
经验分享：请问下，接收后多久会发来proof？接收了20天还没有收到proof

100 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237980, encodeId=c1a1223e98000, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：消化道肿瘤 经验分享：7月份投稿，9月份大修，一拒一修，编辑给大修，10月份修回被拒，拒稿的审稿人强烈建议进行前瞻性实验，AE也建议前瞻，但是这项研究前瞻性过不了伦理。大家觉得argue有用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Wed Nov 20 14:01:14 CST 2024, time=2024-11-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215509, encodeId=e336221550931, content=偏重的研究方向：内镜 经验分享：with editor两个月，催稿后直接拒了，编辑那超级慢，不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25bf5324886, createdName=JOY@111, createdTime=Wed Jul 17 22:15:10 CST 2024, time=2024-07-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2161031, encodeId=c9032161031d1, content=偏重的研究方向：手术;胃癌 经验分享：各位前辈，为何投稿后5天还是new submission? 需要所有作者通过邮件确认作者后编辑才会处理吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 05 12:04:24 CST 2023, time=2023-10-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=925418, encodeId=6e519254188a, content=投稿20多天就小修，修回后十几天就接收，很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64645233302, createdName=147a5940m05暂无昵称, createdTime=Fri Feb 19 10:39:47 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153424, encodeId=d3652153424cb, content=偏重的研究方向：肝胆胰脾的微创治疗;endoscopy;内镜 经验分享：8.2开始editor assigned半个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99b78341791, createdName=ms3000001727854429, createdTime=Fri Aug 18 16:56:10 CST 2023, time=2023-08-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2176172, encodeId=d63c21e617292, content=请问大修，一个审稿人全是评论，另外一位审稿人给了修改意见，大修通过率大概是多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a08760050, createdName=ms6000000523905696, createdTime=Wed Dec 20 19:34:44 CST 2023, time=2023-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178961, encodeId=66e421e8961f1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科;胃癌 经验分享：腹腔镜手术术式投稿。投稿2月给出大修意见，修改提交后10余天接收。想问一下，接收后大约多久会收到缴费的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Wed Jan 03 10:01:09 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195169, encodeId=c7bb2195169fe, content=我想咨询一下各位老师，接受后多久收到OA或者非OA通知，以及Proof，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e435309968, createdName=14885ad9m72(暂无昵称), createdTime=Mon Mar 25 10:57:03 CST 2024, time=2024-03-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2181044, encodeId=89a621810446c, content=偏重的研究方向：外科;胃癌 经验分享：请问下，接收后多久会发来proof？接收了20天还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Fri Jan 12 19:56:56 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1192317, encodeId=0a27119231eec, content=有人弄过这个杂志的visual abstract嘛。编辑要求添加这个，但是我没在官网上找到示例。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Fri Feb 11 13:40:44 CST 2022, time=2022-02-11, status=1, ipAttribution=)]

2022-02-11 yh2

有人弄过这个杂志的visual abstract嘛。编辑要求添加这个，但是我没在官网上找到示例。

119 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务